Streetbeat News

Revenues

ECVT

Ecovyst (NYSE:ECVT) has received mixed analyst ratings over the past three months, with two analysts being bullish and two somewhat bullish. The average 12-month price target has decreased from $13.50 to $10.75. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. Ecovyst's financials show a decline in revenue growth but strong profitability and financial performance metrics. The company faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:04 pm

CVBF

CVB Financial (NASDAQ:CVBF) has been evaluated by 4 analysts over the past three months, with ratings ranging from somewhat bullish to indifferent. The average 12-month price target has decreased slightly to $21.25. Analysts have adjusted their ratings and price targets, reflecting their views on CVB Financial's current market position. Despite challenges in revenue growth, CVB Financial maintains strong net margins, ROE, and ROA, and has a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:04 pm

GLASF

HITI

TLRY

The article discusses how top cannabis companies, Tilray, High Tide, and Glass House Brands, are navigating financial pressures and regulatory uncertainties. High Tide shows positive growth with market expansion and a strong loyalty program. Tilray faces operational losses despite revenue growth, focusing on potential acquisitions to strengthen its medical cannabis segment. Glass House Brands aims for cost leadership in cultivation, with plans to reduce production costs and expand operations. The cannabis sector remains resilient amid market pressures and election uncertainties.

Portfolio Pulse from Patricio Liddle

November 01, 2024 | 8:03 pm

NNN

NNN REIT has been evaluated by 5 analysts over the past three months, with most ratings being indifferent. The average 12-month price target has increased by 3.66% to $48.2. Analysts have adjusted their ratings and price targets, reflecting changing market dynamics. NNN REIT shows strong revenue growth and net margin but faces challenges with ROE.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:01 pm

FXNC

First National (NASDAQ:FXNC) reported Q3 earnings of $0.39 per share, beating the $0.36 estimate, but down 22% from last year. Sales were $14.95M, surpassing the $14.80M estimate and up 8.85% from last year.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 8:01 pm

ONTO

Analysts have recently evaluated Onto Innovation (NYSE:ONTO), with 7 analysts providing ratings ranging from bullish to bearish. The average 12-month price target is $249.29, reflecting a slight increase from the previous target. Onto Innovation has shown strong revenue growth and profitability, but its return on equity lags behind industry averages.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 8:00 pm

USM

United States Cellular shares declined following the release of disappointing Q3 revenue results and a downward revision of FY24 service revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:44 pm

TDS

Telephone and Data Systems (TDS) shares declined following disappointing Q3 financial results and a reduction in FY24 US cellular service revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:39 pm

CHD

Church & Dwight shares rose following the release of strong Q3 financial results and an increase in FY24 net sales guidance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:19 pm

TEVA

Teva Pharmaceuticals presented new data at the Psych Congress 2024 from the IMPACT-TD Registry, highlighting differences in tardive dyskinesia (TD) patient experiences based on psychiatric conditions. The study found fewer TD diagnoses in patients with psychotic disorders compared to those with mood disorders. Teva continues to innovate in mental health treatment with AUSTEDO® XR® and AUSTEDO tablets.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 7:18 pm